Conference abstract · 3 Aug 2015
Conference abstractPublished 2 Nov 2017
Immunotherapeutic approaches for the treatment of drug addiction
Mercer University, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In recent years, there has been an increase in the abuse and addiction of designer recreational drugs, such as MDPV (Methylenedioxypyrovalerone) and alpha-PPP (Ã?±-pyrrolidino propiophenone). These psychostimulant drugs, more commonly referred to as âÂ?Â?bath saltsâÂ?, are synthetic cathinones seen as a cheap alternative to other stimulants such as methamphetiamine and cocaine. Bath salts can result in many adverse effects including increased heart rate, depression and death. In order to combat the abuse of bath salts, we developed a therapeutic microparticulate vaccine to reduce the effects of various psychostimulant drugs/ their analogs on the brain. We characterized the drug taking effect as an increase in locomotory activity. Mice were injected with varying doses of the drug to establish a dose-effect curve for locomotory activity. Next, we formulated the anti-drug vaccine using two approaches: drug encapsulation within BSA (bovine serum albumin) matrix and creating microparticles and drug conjugation to BSA and creating microparticles. After vaccination, using the dose-effect curve as a guide, we injected the mice with the pure drug and correlated the changes in locomotory activity to vaccine efficacy for both approaches. Effective immunization across doses would result in a decrease in locomotory activity indicating a production of antibodies that bind specifically to the drug thereby, neutralizing the effects of the drug on the body. We will validate antibody response (innate and adaptive) and production using a series of in vitro studies including nitric oxide assays and anti-drug binding ELISAs.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 30 Dec 2023
Implications for Diagnosis and Immunotherapeutic Approaches on the Role of Allergens Originating from House Dust Mites
Conference abstract · 17 Sep 2018
Employing chemical glycobiology for immunotherapeutic approaches directed at cancer
Commentary · 1 Jun 2023
The Potential of Immunotherapeutic Agents: Revolutionizing Cancer Treatment and Beyond
Commentary · 1 Jun 2023
Advancing Medicine Through Immunotherapeutic Clinical Trials: Achievements for Innovative Treatments
More from this journal
The newest in Journal of Clinical and Cellular Immunology.
Perspective · 10 Sep 2026
Cellular Pathways Involved in Mucosal Immunity and Protection Against Environmental Challenges
Commentary · 22 Jul 2026
From Bench to Bedside: Reframing the CXCL13/CXCR5 Axis as a Non-Redundant Organizer of Protective Pulmonary Immunity in COVID-19
Commentary · 17 Jul 2026
CD5L:p40, a third wheel to IL-12 and IL-23 biology?
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Keegan Braz Gomes”
- BylineArticles whose byline prints “Kevin Murnane”
- BylineArticles whose byline prints “Martin D’Souza”

